A New Horizon in Gene Editing In the rapidly evolving field of genetic medicine, a groundbreaking development has emerged with…
Search Results: CRISPR (21)
Tannishtha Reya, PhD of UCSD @UCSDHealth discusses using genome-wide CRISPR technology to find leukemia’s vulnerabilities. … A team of researchers…
Tannishtha Reya, PhD of UCSD @UCSDHealth discusses using genome-wide CRISPR technology to find leukemia’s vulnerabilities. _____________ A team of researchers…
Using genetically engineered human pluripotent stem cells, University of California San Diego School of Medicine researchers created a new type…
Arlene Sharpe M.D. Ph.D. Department of Immunology Harvard Medical School presents Discovery of new IO Targets Leveraging CRISPR Filmed at…
New and invigorating methods of tackling acute myeloid leukemia (AML) are being researched at present. In this interview, Saar Gill,…
… Lung cancer remains the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for the…
Zahra Pakbaz, MD, shed light on a range of critical findings from the American Society of Hematology (ASH) meeting, with…
Cell Death: Drug Combo Restores Signaling Ability of Leading Treatment for Blood Cancer Christina Glytsou PhD By Christina Glytsou, PhDAssistant…
Urothelial Cancer: What’s New in 2023? Targeted and Novel Therapies Nataliya Mar MD By Nataliya Mar, MD Good afternoon, everyone.…
Daniel Herranz, PharmD, Ph.D., Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School & Resident…
Daniel Herranz, PharmD, Ph.D., Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School & Resident…
Matthew Tate, MD, Ph.D., Associate Professor of Neurological Surgery and Neurology – Ken and Ruth Davee Department Northwestern University Feinberg…
Johannes A. Schmid, Ph.D. from MedUni Vienna speaks about How inflammatory signaling molecules contribute to carcinogenesis.Link to Article -https://www.sciencedaily.com/releases/2021/02/210217114327.htmThe Whole…
Uri Ben-David, Ph.D. Assistant Professor, Department of Human Molecular Genetics and Biochemistry at the Tel Aviv University speaks about the…
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in…
— First clinical data from Phase 1 study of MGTA-145 show successful mobilization of target number of stem cells in…
Ewelina Morawa, MD Executive Medical Director CRISPR Therapeutics discusses Allogeneic Anti-CD70 CAR T Cells ?for Renal Cell Carcinoma From the…
CRISPR technology is being used to define mechanisms of multiple myeloma (MM) drug resistance. Here, Constantine Mitsiades, MD, PhD, of…
As innovative research investigating acute myeloid leukemia (AML) progresses, the chances of developing effective treatments against the ailment increase. In…
Noopur Raje, MD from the Massachusetts General Hospital, Boston, MA discusses highlights on the in vivo drug screening session in…